Mounjaro pens dosage: how the titration schedule works in practice

Step 1: every Mounjaro course starts at 2.5 mg

Whatever strength you eventually settle on, the first pen is always 2.5 mg. That is not a therapeutic dose in the weight-loss sense; its job is to let your digestive system get used to tirzepatide before anything more demanding arrives. Nausea, the most commonly reported early side effect, tends to be milder when the body has this settling-in period. Four injections at 2.5 mg, one a week, and then your prescriber reviews whether to move you forward.

The injection itself goes just under the skin, in the abdomen, thigh or upper arm. Sites should be rotated from week to week. The pen is pre-filled and pre-set, so there is no measuring or dialling; you confirm the correct strength on the label, press the pen against the skin and follow the steps in the Patient Information Leaflet. Storage matters too: the pens need to be kept refrigerated between 2–8°C, and the exact room-temperature window before use is set out in the Mounjaro SmPC on the eMC — always check that leaflet rather than relying on a general summary.

One thing worth knowing early: the 2.5 mg pen looks identical to higher-strength pens apart from the label colour and printed strength. Double-checking before each injection is a simple habit that prevents a common error. That is it, straightforward once the routine is established.

Step 2: titrating upward, one pen at a time

After four weeks at 2.5 mg, the standard next move is to 5 mg, and so on in 2.5 mg increments, each lasting roughly a month. The full ladder runs: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg. For a more detailed breakdown of what each step involves, the Mounjaro dosage guide on this site covers the clinical reasoning behind each rung.

Titration is not automatic. Each increase needs a prescriber to review your progress and confirm it is appropriate. At nume, that review happens before every repeat supply, and evidence of your current dose is required before a step up is authorised. This is a clinical checkpoint, not a formality. If side effects at a given strength are still causing real difficulty, a prescriber may recommend staying at that strength longer rather than pressing ahead.

Not everyone reaches 15 mg, and that is not a failure. The licensed approach is to find the highest dose you can tolerate well; some people achieve their clinical goals at 5 mg or 7.5 mg and stay there. If you want to understand what the 15 mg pen specifically involves, the 15 mg Mounjaro pens page explains its place in the schedule and the evidence behind it. For context on where the ceiling sits, the maximum dosage of Mounjaro page sets out what the licensed upper limit means in practice.

Step 3: understanding what the dose numbers actually mean

One source of confusion is that Mounjaro doses are described in milligrams on the label, but some people are curious about the corresponding volume or units. Each pen delivers a fixed 0.5 ml subcutaneous dose regardless of the strength; the concentration of tirzepatide per ml changes as the strength goes up, which is why the volume stays constant while the milligram figure varies. If you have seen references to the dose expressed as a volume, the Mounjaro dosage in ml page explains exactly how concentration and volume relate across the six strengths.

There is also sometimes a question about units, particularly among people who have previous experience with insulin or other injectable medicines. The Mounjaro dosage in units page covers that distinction. The short answer is that tirzepatide is prescribed and described in milligrams, not insulin units; thinking in units can lead to misunderstandings, so it is worth getting clear on this before treatment starts.

The specific 5 mg strength, which is the first therapeutic step after the starter dose, has its own practical profile. The Mounjaro 5 mg page covers what to expect at that strength, including how it differs from the opening 2.5 mg experience. Some people also ask about what a 0.6 ml dose refers to, this occasionally comes up in conversations about compounded or unlicensed products, and the 0.6 ml dose explainer addresses that question directly.

The clinical review at every stage

The dosage schedule described above is the licensed framework; how it applies to any individual is always a clinical matter. A prescriber considers your starting weight, any existing health conditions, how you are tolerating each strength and whether your weight-loss progress supports continuing. NICE's appraisal of tirzepatide, TA1026, notes that if fewer than 5% of body weight has been lost after six months at the highest tolerated dose, continuing should be reviewed, that is a clinical conversation, not a self-assessment.

If you are wondering what Mounjaro costs through a private pharmacy, a realistic picture of what the market looks like and what to watch out for is covered on the weight-loss treatments page, which also sets out how treatment through a GPhC-registered pharmacy works from consultation to delivery. Understanding the full dosage picture before you begin is worthwhile, the schedule is designed to protect you as much as to treat you, and knowing what is coming at each stage makes the process significantly less daunting.

If you have questions about your specific situation or want a prescriber to assess your eligibility, you can check your eligibility through a free consultation, reviewed the same working day by a GPhC-registered prescriber. A real clinician reads your answers, there is no automated triage.